If you've worked in pharmacy for more than a few years,
you've probably seen your share of industry shifts. The rise of specialty
pharmacy. The expansion of clinical services. The growth of automation.
But I can't remember another drug class that has changed pharmacy as quickly or
as broadly as GLP-1 medications.
Here's what pharmacy professionals actually need to know to
stay positioned for success.
Whether we're talking about semaglutide, tirzepatide, or the next generation of
weight management therapies already in development, these medications have
reshaped patient expectations, pharmacy workflows, hiring priorities, and even
entire business models.
And now another major shift is underway.
In April, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide
from the 503B bulks list, signaling its intent to significantly limit
large-scale compounding of GLP-1 products.
For some organizations, that's a regulatory story. For
pharmacists and pharmacy leaders, it's also a workforce story. Because
regardless of what happens with compounding, demand for GLP-1 expertise isn't
slowing down. If anything, it's accelerating.
WHAT
CHANGED SO QUICKLY?
At first, GLP-1s were viewed primarily as diabetes medications. Today they're
influencing obesity treatment, cardiovascular care, metabolic health, and
countless patient conversations happening every day across retail, hospital,
ambulatory care, specialty, and telehealth settings.
Patients aren't simply asking whether these medications work. They're asking
how long they'll need them, how to manage side effects, what happens if they
stop, and how to maintain results.
Those aren't questions an app can answer effectively. They're questions
patients want to discuss with someone they trust.
That's where pharmacists come in.
WHAT
DOES THIS MEAN FOR YOU?
The headlines have focused on FDA enforcement. Some
compounding pharmacies built significant revenue around GLP-1 demand and may
face adjustments as regulations tighten. But from a recruiting perspective,
that's only part of the story.
Healthcare organizations are trying to build clinical capacity around a patient
population that isn't going away. Patients using GLP-1 therapies need
education, monitoring, coaching, side-effect management, adherence support, and
help navigating insurance hurdles.
Those needs create opportunities for pharmacists.
THE
SKILLS EMPLOYERS ARE LOOKING FOR
When pharmacy leaders call me today, they aren't asking for someone who can
simply dispense medication.
They're looking for pharmacists who can help patients succeed on therapy.
Clinical Counseling
Many patients begin GLP-1 therapy with unrealistic expectations. Pharmacists
who can set realistic expectations and guide patients through the journey
create tremendous value.
Lifestyle Integration
Patients often discover that medication alone isn't enough. Pharmacists who
understand how GLP-1 therapy fits into a broader care plan are increasingly
valuable members of the healthcare team.
Adherence Support
Many patients discontinue therapy because of side effects, cost concerns,
supply disruptions, or frustration with results.
Insurance Navigation
Coverage remains complicated. Pharmacists who understand reimbursement
challenges help organizations improve both outcomes and patient satisfaction.
WHAT
THIS MEANS FOR YOUR CAREER
1. Become the GLP-1 expert.
2. Strengthen communication skills.
3. Move toward clinical practice.
The pharmacists who understand these medications, communicate effectively, and
build trust with patients will continue to be in demand.
A NOTE
FOR PHARMACY LEADERS
The GLP-1 boom is creating operational challenges for many organizations.
When evaluating candidates, look beyond technical competency. Ask whether they
can build trust with patients, educate effectively, support long-term
adherence, and collaborate across care teams.
THE
BIGGER PICTURE
Every few years, healthcare produces a trend that generates enormous attention.
Some fade. Some transform entire sectors.
GLP-1s appear to belong in the second category.
The medications will evolve. The regulations will evolve. The business models
will evolve.
But one thing is becoming increasingly clear:
Patients need more guidance, not less.
And the pharmacists who can provide that guidance are becoming some of the most
valuable professionals in healthcare.
